image description

Tag: vosclosporin

LRA Congratulates Aurinia on Published Results with FDA-Approved Lupkynis™

May 10, 2021 The highly prestigious medical journal The Lancet published the results of Aurinia’s Phase 3 AURORA 1 study testing Lupkynis™ (voclosporin) in adults with lupus nephritis. Lupkynis was approved by the U.S. Food and Drug Administration based on these data. The AURORA 1 study results showed that Lupkynis in combination with the commonly used […] Read More
Stay informed about events, research developments, and ways you can help. Sign up for updates